Literature DB >> 10908003

The matrix model of outpatient stimulant abuse treatment: history and description.

J L Obert1, M J McCann, P Marinelli-Casey, A Weiner, S Minsky, P Brethen, R Rawson.   

Abstract

The Matrix model was originally developed in response to the cocaine epidemic of the 1980s. The program consists of relapse prevention groups, education groups, social support groups, individual counseling, and urine and breath testing delivered in a structured manner over a 16-week period. The treatment is a directive, nonconfrontational approach which focuses on current issues and behavior change. Several evaluations of the model have supported its usefulness and efficacy with methamphetamine (MA) users. Methamphetamine users appear to respond to treatment similarly to cocaine users and many continue to show improvements at follow-up.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908003     DOI: 10.1080/02791072.2000.10400224

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  19 in total

1.  Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.

Authors:  Mary Hatch-Maillette; Elizabeth A Wells; Suzanne R Doyle; Gregory S Brigham; Dennis Daley; Jessica DiCenzo; Dennis Donovan; Sharon Garrett; Viviana E Horigian; Lindsay Jenkins; Therese Killeen; Mandy Owens; Harold I Perl
Journal:  J Subst Abuse Treat       Date:  2016-06-16

2.  Strategies to encourage adoption in multisite clinical trials.

Authors:  Joseph Guydish; Barbara Tajima; Sarah Turcotte Manser; Martha Jessup
Journal:  J Subst Abuse Treat       Date:  2006-11-22

3.  Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program.

Authors:  Michael L Prendergast; Elizabeth A Hall; John Roll; Umme Warda
Journal:  J Subst Abuse Treat       Date:  2007-11-07

4.  Multi-level assessment protocol (MAP) for adoption in multi-site clinical trials.

Authors:  J Guydish; S T Manser; M Jessup; B Tajima; C Sears; T Montini
Journal:  J Drug Issues       Date:  2005-07-01

5.  Quality of life among treatment seeking methamphetamine-dependent individuals.

Authors:  Rachel Gonzales; Alfonso Ang; Deborah C Glik; Richard A Rawson; Stella Lee; Martin Y Iguchi
Journal:  Am J Addict       Date:  2011-05-31

6.  Reinforcing Abstinence and Treatment Participation among Offenders in a Drug Diversion Program: Are Vouchers Effective?

Authors:  Elizabeth A Hall; Michael L Prendergast; John M Roll; Umme Warda
Journal:  Crim Justice Behav       Date:  2009

7.  A Naturalistic Evaluation of a Group Intervention for Parents of Youth with Substance Use Disorders.

Authors:  Victoria Ameral; Amy Yule; James McKowen; Brandon G Bergman; Jessica Nargiso; John F Kelly
Journal:  Alcohol Treat Q       Date:  2019-07-01

8.  Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003.

Authors:  Moupali Das-Douglas; Grant Colfax; Andrew R Moss; David R Bangsberg; Judith A Hahn
Journal:  J Urban Health       Date:  2007-12-27       Impact factor: 3.671

9.  Glial cell modulators attenuate methamphetamine self-administration in the rat.

Authors:  Sarah E Snider; Elizabeth S Hendrick; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2013-01-31       Impact factor: 4.432

10.  How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use.

Authors:  Gantt P Galloway; Edward G Singleton
Journal:  Subst Abuse       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.